At Samarpan, we understand substance use disorders and offer an integrated substance use treatment program in Mumbai to help heal and empower everyone affected by these serious health and social problems. Substance use disorder can develop from the use of a variety of substances opioids, including alcohol, tobacco, and prescription drugs. It affects the brain and behavior. It is a treatable condition, and treatment may involve a combination of medication, behavioral therapy, and support groups.
Substance use disorder treatment often involves a combination of different approaches, including medication-assisted treatment, behavioral therapy, and support groups. The specific treatment plan may vary depending on the individual's needs, the type of substance used, and the severity of the addiction.
Medication-assisted treatment involves the use of medications, such as methadone or buprenorphine, to help manage withdrawal symptoms and cravings. This approach is often used for opioid addiction. Behavioral therapy includes approaches such as cognitive-behavioral therapy (CBT), which helps individuals recognize and change negative thought patterns and behaviors related to substance use, and motivational interviewing, which helps individuals increase their motivation to change their behavior.
Support groups, such as 12-step programs like Alcoholics Anonymous or Narcotics Anonymous, can provide individuals with a sense of community and accountability. In addition to these approaches, other strategies, such as exercise, meditation, and healthy lifestyle changes, can also be helpful in supporting long-term recovery. It is important to work with a healthcare professional or addiction specialist to develop a personalized treatment plan that meets your specific needs and goals.
Transparency Market Research (TMR) has published a new report titled, “Substance Abuse Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.
The report suggests that emerging initiatives by manufacturers and governments and rise in abuse of prescription drugs are anticipated to boost the global substance abuse treatment market from 2018 to 2026.
Key events in the market include submission of provisional patent application to the USPTO for proprietary pure cannabidiol compositions by Normaco in October 2018, approval of SUBLOCADE, by the FDA, launched in the U.S. in March 2018, and U.S. FDA approval for the ANDA for methadone hydrochloride (5 mg and 10 mg) tablets for Glenmark Pharmaceuticals and its strategic partner Elite Pharmaceuticals, Inc in August 2018.
Read Report Overview - https://www.transparencymarketresearch.com/substance-abuse-treatment-market.htmlAlcohol addiction treatment segment to expand at significantly high growth rateThe report offers detailed segmentation of the global substance abuse treatment market.
High market attractiveness of drug abuse treatment and nicotine addiction treatment segments is due to the availability of different nicotine replacement products over-the-counter in order to combat tobacco and nicotine addiction and an increase in adoption of prescription opioids or illicit drugs.
Nicotine replacement therapy (NRT) products contain low concentration of nicotine, which helps reduce cravings caused by nicotine addiction over time.
